1. FDA, Meridia® label, Available on https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020632s032lbl.pdf (Accessed October, 31 2018).
2. EMA, European Medicines Agency recommends suspension of marketing authorisations forsibutramine, Available on https://www.ema.europa.eu/en/medicines/human/referrals/sibutramine (Accessed November, 22 2018).
3. Drug Safety and Availability - Questions and Answers: FDA Recommends Against the Continued Use of Meridia (sibutramine);FDA,2016
4. Standard Prohibited List, International Standard;World Anti-Doping Agency,2017
5. Quantitative determination of sibutramine in adulterated herbal slimming formulations by TLC-image analysis method;Phattanawasin;Forensic Sci. Int.,2012